PATENT CLAIM ANALYSIS

Application Number: 16360811
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "235800"]

Abstract:
Compounds of formula (I) which are inhibitors of Bub 1 kinase, processes for their production and their use as pharmaceuticals.

Claim (Index 8):
A process for the manufacture of the compound of formula (I) according to  claim 1 , wherein\n a compound of formula (Ib) whereby R 1 , R 2 , R 3 , R 6 , R 7 , R 8  and m have the meaning according to  claim 1  and R\u2032 is 1-6C-alkyl or benzyl, is treated with a suitable acid system to cleave the benzylic group in order to obtain a compound of formula 1-5 followed by reacting the compound of formula 1-5 with a compound of general formula (B), wherein R 2 , R 3 , R 4  and n have the meaning according to  claim 1  and X represents a leaving group, in a suitable solvent system, in the presence of a suitable base, in a temperature range from room temperature to the boiling point of the respective solvent, to furnish compounds of general formula (I).

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14350160', '14365895', '14400315', '14900599', '15032957']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8224431101395893
- 35 USC 102 Novelty (BERT): 0.6230760389554322
- Combined Prediction Score: 0.8025064030211736
- Mean Citation Score: 480.713422
- Max Citation Score: 558.1653
- Similarity Product: 539.7811812960506

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test